Inclusion Criteria:
* Is male or female ≥ 18 and ≤ 50 years of age.
* Requires extraction of 2 or more third molars. At least 2 of the third molars must be a fully or partially bone impacted mandibular molar.
* Experiences moderate-to-severe pain defined as a score ≥ 2 on the 4-point categorical scale, and a score of ≥ 5 measured by the 0-10 Numeric Pain Rating Scale (NPRS) within 4.5 hours after surgery.
* Has a body weight ≥ 45 kg and a body mass index (BMI) ≤ 35 kg/m2.
* Female subjects of child-bearing potential must have used an acceptable method of contraception for at least 30 days prior to randomization and agree to continue use until at least 48 hours post-discharge from the clinic. To be considered not of child-bearing potential, females must be surgically sterile (defined as bilateral tubal ligation, bilateral oophorectomy, or hysterectomy) or post-menopausal (defined as no menses for 12 months without an alternative medical cause).
* Free of clinically significant abnormal findings as determined by medical history, physical examination, vital signs, and laboratory tests.
* Able to provide written informed consent.
* Is willing and able to comply with study requirements (including diet and smoking restrictions), complete the pain evaluations, remain at the study site for 12 hours post-dose on Day 1, and complete an in-person follow-up visit on Day 8 (± 2 days)
Exclusion Criteria:
* Known hypersensitivity or allergy to acetaminophen, NSAIDs (including ibuprofen), aspirin, study drug ingredients, anesthetics, or antibiotics.
* History of active or previous peptic ulceration, gastrointestinal bleeding or perforation, heart failure, renal impairment, uncontrolled hypertension, exercise-induced asthma, nasal polyps, or chronic rhinitis; or history or presence of hepatic impairment, or clinically significant baseline laboratory abnormalities at Screening, defined as serum ALT or AST \> 1.5× the Upper Limit of Normal (ULN), or total bilirubin \> 1.5× ULN (unless attributable to documented Gilbert's syndrome), uncontrolled hypertension, exercise-induced asthma, nasal polyps, or chronic rhinitis.
* Complications from tooth extraction resulting in a "severe" surgical trauma rating.
* Dental surgery within 60 days prior to Day 1.
* Positive urine drug screen or alcohol breathalyzer test.
* Positive pregnancy test (serum at screening, urine pre-surgery on Day 1) or lactating.
* Known history or suspected (in the opinion of the investigator) of alcoholism or drug abuse within 2 years.
* Concomitant medications that confound pain assessment. Selective serotonin reuptake inhibitors (SSRIs) and serotonin and noradrenaline reuptake inhibitors (SNRIs) are permitted if on a stable dose for ≥ 4 weeks prior to Screening.
* History of chronic use (defined as daily use for \> 2 weeks within 6 months) of NSAIDs, opiates, or glucocorticoids for any condition within 6 months prior to dosing.
* Difficulty swallowing oral medication.
* Investigational drug exposure within 30 days or 5 half-lives.